SOW
PTGX icon

State of Wyoming’s Protagonist Therapeutics PTGX Stock Holding History

State of Wyoming’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
+3,102
New +$324K 0.04% 568
2026
Q1 		– Sell
-2,070
Closed -$181K – 1987
2025
Q4 		$181K Buy
+2,070
New +$169K 0.02% 1045
2025
Q3 		– Sell
-3,985
Closed -$220K – 2013
2025
Q2 		$220K Buy
3,985
+2,528
+174% +$121K 0.03% 847
2025
Q1 		$70.5K Sell
1,457
-6,375
-81% -$267K 0.01% 1320
2024
Q4 		$302K Buy
7,832
+832
+12% +$36.3K 0.04% 554
2024
Q3 		$315K Buy
7,000
+5,509
+369% +$223K 0.05% 399
2024
Q2 		$51.7K Buy
+1,491
New +$43.7K 0.01% 1310
2021
Q4 		– Sell
-26
Closed – – 1954
2021
Q3 		$0 Sell
26
-95
-79% -$4.05K ﹤0.01% 1314
2021
Q2 		$5K Buy
121
+64
+112% +$2.11K ﹤0.01% 1077
2021
Q1 		$1K Buy
+57
New +$1.44K ﹤0.01% 495

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State of Wyoming's PTGX Position: Q2 2026 in Review

State of Wyoming opened a new position in Protagonist Therapeutics (PTGX) in Q2 2026: 3,102 shares worth $380K. The stake represents 0.04% of the portfolio and ranks #568 among its holdings. This is a return to the name: State of Wyoming previously reported a position in PTGX as recently as Q4 2025.

State of Wyoming first reported a position in PTGX in Q1 2021 and has held it in 10 quarters since. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • State of Wyoming held 3,102 shares of Protagonist Therapeutics worth $380K as of Q2 2026.
  • Protagonist Therapeutics was a new State of Wyoming position in Q2 2026.
  • Protagonist Therapeutics made up 0.04% of State of Wyoming's portfolio in Q2 2026, its #568 holding.
  • State of Wyoming first reported a position in Protagonist Therapeutics in Q1 2021 and has held it in 10 quarters since.
  • 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.